| PERIOD ENDING | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | 30-Sep-08 | | Total Revenue | 4,082 | 3,577 | 4,860 | 5,113 | | Cost of Revenue | 1,537 | 1,470 | 1,898 | 2,128 | | | Gross Profit | 2,545 | 2,107 | 2,962 | 2,985 | | | Operating Expenses | | Research Development | 1,126 | 1,243 | 1,225 | 1,129 | | Selling General and Administrative | 2,411 | 2,651 | 3,055 | 2,746 | | Non Recurring |
-
|
-
|
-
|
-
| | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | (992) | (1,787) | (1,318) | (890) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 51 | 22 | 37 | 75 | | Earnings Before Interest And Taxes | (944) | (1,768) | (1,284) | (811) | | Interest Expense |
-
|
-
|
-
|
-
| | Income Before Tax | (944) | (1,768) | (1,284) | (811) | | Income Tax Expense | 1 |
-
| (16) |
-
| | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | (945) | (1,768) | (1,268) | (811) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (945) | (1,768) | (1,268) | (811) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($945) | ($1,768) | ($1,268) | ($811) |
|
0.02% Nasdaq 
Income Statement
